openPR Logo
Press release

Radiotheranostics Market Share, Size, Growth Rate, Trends Analysis And Forecast To 2033

Radiotheranostics Market

Radiotheranostics Market

The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.

Radiotheranostics Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.

The Market Size Is Expected To Reach $14.61 billion In 2028 At A CAGR Of 13.7%.

The radiotheranostics market size has grown rapidly in recent years. It will grow from $7.57 billion in 2023 to $8.74 billion in 2024 at a compound annual growth rate (CAGR) of 15.3%. The growth in the historic period can be attributed to advancements in nuclear medicine, rise in cancer cases, personalized medicine development, advances in radiopharmaceuticals, regulatory approvals and standards.

The radiotheranostics market size is expected to see rapid growth in the next few years. It will grow to $14.61 billion in 2028 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to advancements in targeted cancer therapies, expansion in oncology research, rise in chronic diseases, growth in theranostic applications. Major trends in the forecast period include theranostic radiopharmaceutical development, expanding applications beyond oncology, personalized radiopharmaceuticals, nanotechnology in radiotheranostics, regulatory shifts and standardization.

Request A Sample Of This Report - https://www.thebusinessresearchcompany.com/sample.aspx?id=12270&type=smp

Radiotheranostics Market Major Segments
The radiotheranostics market covered in this report is segmented -

1) By Radioisotope: Technetium-99, Gallium-68, Iodine-131, Iodine-123, Fludeoxyglucose-18F, Yttrium-90, Lutetium (Lu) 177, Copper (Cu) 67, Copper (Cu) 64, Other Radioisotopes
2) By Approach: Targeted Therapeutic, Targeted Diagnostic
3) By Application: Oncology, Non-Oncology
4) By End-Users: Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, Other End-Users

Key Driver - Rising Prevalence Of Cancer To Drive Market Growth

The increasing prevalence of cancer is expected to propel the growth of the radiotheranostics market going forward. Cancer is a condition in which some cells in the body develop uncontrollably and spread to other regions of the body. Radiotheranostics medicines are commonly employed in cancer to offer the ultimate notion of customized medicine by using paired diagnostic and therapeutic radionuclide probes for the selective and targeted detection and treatment of specific (typically cancer) cells, each of which is suited to the patient's underlying condition to enhance treatment efficiency and better clinical output. For instance, according to Cancer Research UK, a UK-based cancer research organization, approximately 18 million new cancer cases were detected in 2020. Further, there would be 28 million new cancer cases globally each year by 2040, a 54.9% increase over 2020, and is predicted to be more prominent in males (60.6% increase) than girls (48.8% increase). Therefore, the increasing prevalence of cancer drives the radiotheranostics market.

Customise This Report As Per Your Requirements - https://www.thebusinessresearchcompany.com/Customise?id=12270&type=smp

Prominent Trend - Product Innovations Transforming The Radiotheranostics Market

Product innovations are a key trend gaining popularity in the radiotheranostics market. Significant companies are concentrating their efforts on creating innovative products to strengthen their position in the market. For instance, in May 2023, Advanced Cyclotron Systems Inc., a Canada-based company that supplies and services cyclotrons predominantly used for producing medical isotopes, introduced TR-ALPHA for producing alpha-emitting radioisotopes to treat cancer. It is an appropriate solution to the market demand for a low-cost cyclotron capable of producing vast amounts of Astatine-211, one of the most promising alpha-emitting radioisotopes. The TR-ALPHA is also far smaller, less costly, and simpler to run than previous cyclotron models capable of manufacturing alpha-emitting radioisotopes. It is the ideal solution for hospitals, researchers, and institutions interested in running a dedicated cyclotron to efficiently produce enormous amounts of therapeutic alpha-emitting radioisotopes.

Radiotheranostics Market Players
Major companies operating in the radiotheranostics market report are Lantheus Holdings Inc., Cardinal Health Inc., GE Healthcare Inc., Bayer AG, Novartis AG, Siemens Healthineers, Boston Scientific Corporation, Terumo Corporation, Orano Med, Curium SAS, IBA Molecular, The Eckert & Ziegler Group, Advanced Accelerator Applications (AAA), Telix Pharmaceuticals Limited., Abdera Therapeutics, Blue Earth Diagnostics, Sirtex Medical Limited, Y-mAbs Therapeutics Inc., ITM Radiopharma, NorthStar Medical Radioisotopes LLC, Trasis S.A., Molecular Targeting Technologies Inc., RadioMedix Inc, Clarity Pharmaceuticals, Actinium Pharmaceuticals Inc., Navidea Biopharmaceuticals Inc.

View The Full Report Here - https://www.thebusinessresearchcompany.com/report/radiotheranostics-global-market-report

Largest And Fastest Growing Region In The Market
North America was the largest region in the radiotheranostics market in 2023. The regions covered in the radiotheranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Radiotheranostics Market Report Structure
3. Radiotheranostics Market Trends And Strategies
4. Radiotheranostics Market - Macro Economic Scenario
5. Radiotheranostics Market Size And Growth
…..
27. Radiotheranostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiotheranostics Market Share, Size, Growth Rate, Trends Analysis And Forecast To 2033 here

News-ID: 3524239 • Views:

More Releases from The Business Research Company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Radiotheranostics

Radiotheranostics Market Is Going to Boom |• Novartis • Bayer
According to Worldwide Market Reports (WMR) highlights that the "Radiotheranostics Market" is projected to experience substantial growth in the coming years. This report provides a comprehensive analysis of the market landscape using an integrated approach that includes research methodology, market size evaluation, data compilation, and insights gathered from multiple credible sources. The study covers critical market elements such as market dynamics, drivers, restraints, challenges, threats, growth opportunities, development trends, technological advancements,
Radiotheranostics Market Future Trends and Scope Analysis Report
"Radiotheranostics Market" in terms of revenue was estimated to be worth $ 2.54 billion in 2024 and is poised to reach $ 8.73 billion by 2034, growing at a CAGR of 6.0% from 2025 to 2034 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1499 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global radiotheranostics market are: • Technological advancement • Increasing awareness • Increasing Cancer Rate The following
Radiotheranostics Market Report- Expansive Coverage on the Profit Sources
Radiotheranostics Market to reach over USD 1.5 billion by the year 2031 - Exclusive Report by InsightAce Analytic "Radiotheranostics Market" in terms of revenue was estimated to be worth $1.84 billion in 2023 and is poised to reach $4.36 billion by 2031, growing at a CAGR of 11.58% from 2024 to 2031 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1499 Latest Drivers Restraint and Opportunities
Radiotheranostics Market
"Radiotheranostics Market" in terms of revenue was estimated to be worth $1.84 billion in 2023 and is poised to reach $4.36 billion by 2031, growing at a CAGR of 11.58% from 2024 to 2031 according to a new report by InsightAce Analytic. Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1499 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global radiotheranostics market are: • Technological advancement • Increasing awareness • Increasing
Radiotheranostics Market Current Scenario with Future Aspect Analysis
"Radiotheranostics Market" in terms of revenue was estimated to be worth $1.84 billion in 2023 and is poised to reach $4.36 billion by 2031, growing at a CAGR of 11.58% from 2024 to 2031 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1499 Latest Drivers Restraint and Opportunities Market Snapshot: Key factors influencing the global radiotheranostics market are: • Technological advancement • Increasing awareness • Increasing Cancer Rate The following are the
Radiotheranostics Market Latest Survey Report 2024
Radiotheranostics Market Radiotheranostics Market to reach over USD 4.36 billion by the year 2031 - Exclusive Report by InsightAce Analytic "Radiotheranostics Market" in terms of revenue was estimated to be worth $1.84 billion in 2023 and is poised to reach $4.36 billion by 2031, growing at a CAGR of 11.58% from 2024 to 2031 according to a new report by InsightAce Analytic. Get Free Sample Report @ https://www.insightaceanalytic.com/request-sample/1499 Latest Drivers Restraint and